Products

What will AGI do for Acarbose?

This classification denotes a glucosidase inhibitor and anti-diabetic agent with the molecular formula C25H43NO18, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) T58MSI464G, chemically known as o-4,6-dideoxy-4-(((1s,4r,5s,6s)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-d-glucopyranosyl-(1->4)-o-alpha-d-glucopyranosyl-(1->4)-d-glucose but more generally known as acarbose, which bears US NIH Compound Identifier 41774. Acarbose most often comes in forms base, hexasaccharide, pentasaccharide, and trisaccharide. European Medicines Agency schedules Acarbose in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07368MIG. The term ACARBOSE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 33, No. 10 1979, List 19) WHO schedules acarbose in its Anatomical Therapeutic Chemical (ATC) Classification. ACARBOSE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule acarbose under HS 29329970 and SITC 51569. As of Q4 2014, ACARBOSE remains US FDA's Preferred Term for this commodity. Acarbose bears US NLM identifiers UMLS ID C0591572 and NCI Concept Code C983. SMILES: O(C1C(O)C(O)C(OC1CO)OC1C(O)C(O)C(OC1CO)O)C1OC(C(NC2C(O)C(O)C(O)C(=C2)CO)C(O)C1O)C.